Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIOX Bioceres Crop Solutions	$3.47 +1.5%	$4.39	$3.30 ▼ $11.41	$214.47M	0.44	122,628 shs	129,333 shs
FVR FrontView REIT	$11.33 -3.7%	$11.90	$10.61 ▼ $19.76	$224.64M	N/A	160,960 shs	452,049 shs
LOAN Manhattan Bridge Capital	$5.50 +0.8%	$5.34	$4.74 ▼ $6.05	$62.46M	0.34	22,104 shs	33,005 shs
OACC Oaktree Acquisition Corp. III Life Sciences	$10.47	$10.48	$9.95 ▼ $10.85	$234.79M	N/A	18,544 shs	1,811 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIOX Bioceres Crop Solutions	+1.46%	-7.47%	-30.46%	-24.40%	-68.74%
FVR FrontView REIT	-3.82%	-11.62%	-9.58%	-10.29%	+1,132,999,900.00%
LOAN Manhattan Bridge Capital	+0.75%	+1.31%	-3.66%	+6.51%	+1.49%
OACC Oaktree Acquisition Corp. III Life Sciences	0.00%	0.00%	+0.19%	+0.77%	+1,046,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BIOX Bioceres Crop Solutions	3.2039 of 5 stars	3.5	4.0	0.0	0.0	3.9	0.0	1.3
FVR FrontView REIT	1.7524 of 5 stars	3.1	0.0	2.5	0.0	1.0	0.0	0.6
LOAN Manhattan Bridge Capital	2.4588 of 5 stars	0.0	4.0	1.7	0.0	2.8	1.7	1.3
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIOX Bioceres Crop Solutions	3.00	Buy	$8.38	141.35% Upside
FVR FrontView REIT	2.20	Hold	$15.10	33.27% Upside
LOAN Manhattan Bridge Capital	0.00	N/A	N/A	N/A
OACC Oaktree Acquisition Corp. III Life Sciences	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest LOAN, FVR, BIOX, and OACC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/15/2025	BIOX Bioceres Crop Solutions	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$7.00 ➝ $6.00
7/11/2025	FVR FrontView REIT	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$13.50
6/17/2025	FVR FrontView REIT	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Underperform	$15.00 ➝ $11.00
6/17/2025	FVR FrontView REIT	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$14.00 ➝ $12.00
6/10/2025	FVR FrontView REIT	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$15.00 ➝ $14.00
5/6/2025	FVR FrontView REIT	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$15.00

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIOX Bioceres Crop Solutions	$464.80M	0.47	$0.40 per share	8.77	$5.56 per share	0.62
FVR FrontView REIT	$66.68M	3.24	$0.48 per share	23.37	$30.23 per share	0.37
LOAN Manhattan Bridge Capital	$9.69M	6.49	$0.50 per share	10.99	$3.80 per share	1.45
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIOX Bioceres Crop Solutions	$3.24M	-$0.14	N/A	9.13	1.46	-2.14%	-2.37%	-0.99%	9/8/2025 (Estimated)
FVR FrontView REIT	-$22.21M	N/A	0.00	9.52	N/A	N/A	N/A	N/A	8/13/2025 (Estimated)
LOAN Manhattan Bridge Capital	$5.59M	$0.47	11.70	∞	N/A	59.04%	12.68%	8.07%	10/21/2025 (Estimated)
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest LOAN, FVR, BIOX, and OACC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	FVR FrontView REIT	$0.31	N/A	N/A	N/A	$16.20 million	N/A
7/22/2025	Q2 2025	LOAN Manhattan Bridge Capital	$0.12	$0.12	N/A	$0.12	N/A	$2.36 million
5/21/2025	Q3 2025	BIOX Bioceres Crop Solutions	-$0.10	-$0.02	+$0.08	-$0.02	$61.80 million	$59.60 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIOX Bioceres Crop Solutions	N/A	N/A	N/A	N/A	N/A
FVR FrontView REIT	$0.86	7.59%	N/A	N/A	N/A
LOAN Manhattan Bridge Capital	$0.46	8.36%	N/A	97.87%	1 Years
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A	N/A	N/A

Latest LOAN, FVR, BIOX, and OACC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/28/2025	LOAN Manhattan Bridge Capital	quarterly	$0.1150	8.47%	10/8/2025	10/8/2025	10/15/2025
5/15/2025	FVR FrontView REIT	quarterly	$0.2150	7.4%	6/30/2025	6/30/2025	7/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIOX Bioceres Crop Solutions	0.22	1.02	0.74
FVR FrontView REIT	0.60	0.17	0.17
LOAN Manhattan Bridge Capital	N/A	2.79	2.79
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIOX Bioceres Crop Solutions	17.68%
FVR FrontView REIT	N/A
LOAN Manhattan Bridge Capital	21.84%
OACC Oaktree Acquisition Corp. III Life Sciences	N/A

Insider Ownership

Company	Insider Ownership
BIOX Bioceres Crop Solutions	2.31%
FVR FrontView REIT	4.30%
LOAN Manhattan Bridge Capital	24.50%
OACC Oaktree Acquisition Corp. III Life Sciences	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIOX Bioceres Crop Solutions	500	62.71 million	61.26 million	Optionable
FVR FrontView REIT	N/A	19.09 million	18.27 million	N/A
LOAN Manhattan Bridge Capital	6	11.44 million	8.64 million	Optionable
OACC Oaktree Acquisition Corp. III Life Sciences	N/A	22.42 million	N/A	N/A

LOAN, FVR, BIOX, and OACC Headlines

Recent News About These Companies

Picton Mahoney Asset Management Takes Position in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

August 1 at 5:22 AM | marketbeat.com

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Shares Down 0.1% - What's Next?

July 4, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
3 Short Squeeze Candidates With Big Catalysts on the Horizon
By Dan Schmidt | July 25, 2025
View 3 Short Squeeze Candidates With Big Catalysts on the Horizon
How a Government Loan Changes the Game for Plug Power
By Jeffrey Neal Johnson | July 4, 2025
View How a Government Loan Changes the Game for Plug Power
America Wants Drone Dominance: Are These Stocks Ready to Soar?
By Chris Markoch | July 20, 2025
View America Wants Drone Dominance: Are These Stocks Ready to Soar?
3 Catalysts Driving Plug Power’s Turnaround Case
By Jeffrey Neal Johnson | July 18, 2025
View 3 Catalysts Driving Plug Power’s Turnaround Case

LOAN, FVR, BIOX, and OACC Company Descriptions

Bioceres Crop Solutions NASDAQ:BIOX

$3.47 +0.05 (+1.46%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$3.47 0.00 (0.00%)

As of 08/1/2025 04:10 PM Eastern

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

FrontView REIT NYSE:FVR

$11.33 -0.44 (-3.74%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$11.30 -0.03 (-0.22%)

As of 08/1/2025 04:04 PM Eastern

FrontView REIT specializes in real estate investing.

Manhattan Bridge Capital NASDAQ:LOAN

$5.50 +0.04 (+0.75%)

Closing price 08/1/2025 03:50 PM Eastern

Extended Trading

$5.76 +0.26 (+4.78%)

As of 08/1/2025 05:54 PM Eastern

Manhattan Bridge Capital, Inc., a real estate finance company, originates, services, and manages a portfolio of first mortgage loans in the United States. The company offers short-term, secured, and non-banking loans to real estate investors to fund acquisition, renovation, rehabilitation, or development of residential or commercial properties. Its loans are secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was founded in 1989 and is headquartered in Great Neck, New York.

Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC

$10.47 0.00 (0.00%)

As of 08/1/2025 12:39 PM Eastern

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time